{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:52Z","timestamp":1740144112918,"version":"3.37.3"},"reference-count":45,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["502-03\/8-000\/01\/502-64-094"],"award-info":[{"award-number":["502-03\/8-000\/01\/502-64-094"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00005-017-0493-3","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T08:27:10Z","timestamp":1507883230000},"page":"267-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Are We Right to Consider Mesenchymal Stem Cells to Be a New Perspective for Patients with Juvenile Idiopathic Arthritis?"],"prefix":"10.2478","volume":"66","author":[{"given":"Krzysztof","family":"Orczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-0448","authenticated-orcid":false,"given":"Elzbieta","family":"Smolewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"493_CR1","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1002\/eji.201141542","volume":"41","author":"H Abdelrazik","year":"2011","unstructured":"Abdelrazik H, Spaggiari GM, Chiossone L et al (2011) Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol 41:3281\u20133290","journal-title":"Eur J Immunol"},{"key":"493_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/BOR.0000000000000370","volume":"29","author":"S Ansboro","year":"2017","unstructured":"Ansboro S, Roelofs AJ, De Bari C (2017) Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both? Curr Opin Rheumatol 29:201\u2013207","journal-title":"Curr Opin Rheumatol"},{"key":"493_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew A, Sturgeon C, Siatskas M et al (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42\u201348","journal-title":"Exp Hematol"},{"key":"493_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","volume":"46","author":"C Bocelli-Tyndall","year":"2007","unstructured":"Bocelli-Tyndall C, Bracci L, Spagnoli G et al (2007) Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology 46:403\u2013408","journal-title":"Rheumatology"},{"key":"493_CR5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V99.3.768","volume":"99","author":"RK Burt","year":"2002","unstructured":"Burt RK, Slavin S, Burns WH, Marmont AM (2002) Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 99:768\u2013784","journal-title":"Blood"},{"key":"493_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jcyt.2012.10.017","volume":"15","author":"FG Calkoen","year":"2013","unstructured":"Calkoen FG, Brinkman DM, Vervat C et al (2013) Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses. CytoTherapy 15:280\u2013291","journal-title":"CytoTherapy"},{"key":"493_CR7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","volume":"12","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Carubbi F, Liakouli V et al (2013) Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. Autoimmun Rev 12:709\u2013716","journal-title":"Autoimmun Rev"},{"key":"493_CR8","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.97.7.3213","volume":"97","author":"DC Colter","year":"2000","unstructured":"Colter DC, Class R, DiGirolamo CM et al (2000) Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97:3213\u20133218","journal-title":"Proc Natl Acad Sci USA"},{"key":"493_CR9","doi-asserted-by":"crossref","unstructured":"Contreras RA, Figueroa FE, Djouad F et al (2016) Mesenchymal stem cells regulate the innate and adaptive immune responses dampening arthritis progression. Stem Cells Int 2016:3162743","DOI":"10.1155\/2016\/3162743"},{"key":"493_CR10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","volume":"28","author":"RJ Deans","year":"2000","unstructured":"Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875\u2013884","journal-title":"Exp Hematol"},{"key":"493_CR11","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Nicola Di","year":"2002","unstructured":"Di Nicola M, Carlo-Stella C, Magni M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838\u20133843","journal-title":"Blood"},{"key":"493_CR12","doi-asserted-by":"crossref","first-page":"R1304","DOI":"10.1186\/ar1827","volume":"7","author":"F Djouad","year":"2005","unstructured":"Djouad F, Bony C, Haupl T et al (2005) Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7:R1304\u2013R1315","journal-title":"Arthritis Res Ther"},{"key":"493_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","volume":"91","author":"K English","year":"2013","unstructured":"English K (2013) Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91:19\u201326","journal-title":"Immunol Cell Biol"},{"key":"493_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein AJ, Chailakhyan RK, Latsinik NV et al (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331\u2013340","journal-title":"Transplantation"},{"key":"493_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","volume":"3","author":"G Giancane","year":"2016","unstructured":"Giancane G, Consolaro A, Lanni S et al (2016) Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther 3:187\u2013207","journal-title":"Rheumatol Ther"},{"key":"493_CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3345\/kjp.2010.53.11.921","volume":"53","author":"YS Hahn","year":"2010","unstructured":"Hahn YS, Kim JG (2010) Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis. Korean J Pediatr 53:921\u2013930","journal-title":"Korean J Pediatr"},{"key":"493_CR17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ng.2614","volume":"45","author":"A Hinks","year":"2013","unstructured":"Hinks A, Cobb J, Marion MC et al (2013) Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 45:664\u2013669","journal-title":"Nat Genet"},{"key":"493_CR18","doi-asserted-by":"crossref","unstructured":"Hou J, Ouyang Y, Deng H et al (2016) Whole-genome expression analysis and signal pathway screening of synovium-derived mesenchymal stromal cells in rheumatoid arthritis. Stem Cells Int 2016:1375031","DOI":"10.1155\/2016\/1375031"},{"key":"493_CR19","first-page":"1","volume":"35","author":"JL Huang","year":"2012","unstructured":"Huang JL (2012) New advances in juvenile idiopathic arthritis. Chang Gung Med J 35:1\u201314","journal-title":"Chang Gung Med J"},{"key":"493_CR20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"CH Jo","year":"2014","unstructured":"Jo CH, Lee YG, Shin WH et al (2014) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells 32:1254\u20131266","journal-title":"Stem Cells"},{"key":"493_CR21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.gt.3302019","volume":"10","author":"C Jorgensen","year":"2003","unstructured":"Jorgensen C, Djouad F, Apparailly F et al (2003) Engineering mesenchymal stem cells for immunotherapy. Gene Ther 10:928\u2013931","journal-title":"Gene Ther"},{"key":"493_CR22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard.2007.076174","volume":"67","author":"MC Kastrinaki","year":"2008","unstructured":"Kastrinaki MC, Sidiropoulos P, Roche S et al (2008) Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 67:741\u2013749","journal-title":"Ann Rheum Dis"},{"key":"493_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/14728222.2013.746954","volume":"17","author":"RJ MacFarlane","year":"2013","unstructured":"MacFarlane RJ, Graham SM, Davies PS et al (2013) Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Expert Opin Ther Targets 17:243\u2013254","journal-title":"Expert Opin Ther Targets"},{"key":"493_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442","journal-title":"Nat Rev Immunol"},{"key":"493_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5966\/sctm.2012-0184","volume":"2","author":"SM Melief","year":"2013","unstructured":"Melief SM, Zwaginga JJ, Fibbe WE et al (2013) Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med 2:455\u2013463","journal-title":"Stem Cells Transl Med"},{"key":"493_CR26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS et al (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42\u201349","journal-title":"Nat Med"},{"key":"493_CR27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/0961203310361482","volume":"19","author":"Y Nie","year":"2010","unstructured":"Nie Y, Lau C, Lie A et al (2010) Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 19:850\u2013859","journal-title":"Lupus"},{"key":"493_CR28","first-page":"1000","volume":"3","author":"D Noel","year":"2002","unstructured":"Noel D, Djouad F, Jorgense C (2002) Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 3:1000\u20131004","journal-title":"Curr Opin Investig Drugs"},{"key":"493_CR29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/pr.2011.68","volume":"71","author":"GA Norambuena","year":"2012","unstructured":"Norambuena GA, Khoury M, Jorgensen C (2012) Mesenchymal stem cells in osteoarticular pediatric diseases: an update. Pediatr Res 71:452\u2013458","journal-title":"Pediatr Res"},{"key":"493_CR30","doi-asserted-by":"crossref","first-page":"35933","DOI":"10.1038\/srep35933","volume":"6","author":"MJ Park","year":"2016","unstructured":"Park MJ, Lee SH, Moon SJ et al (2016) Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis. Sci Rep 6:35933","journal-title":"Sci Rep"},{"key":"493_CR31","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"493_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143\u2013147","journal-title":"Science"},{"key":"493_CR33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. The Lancet 369:767\u2013778","journal-title":"The Lancet"},{"key":"493_CR34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5966\/sctm.2015-0299","volume":"5","author":"G Shalev-Malul","year":"2016","unstructured":"Shalev-Malul G, Soler DC, Ting AE et al (2016) Development of a functional biomarker for use in cell-based therapy studies in seropositive rheumatoid arthritis. Stem Cells Transl Med 5:628\u20136321","journal-title":"Stem Cells Transl Med"},{"key":"493_CR35","doi-asserted-by":"crossref","first-page":"e2524","DOI":"10.1038\/cddis.2016.442","volume":"7","author":"TH Shin","year":"2016","unstructured":"Shin TH, Kim HS, Kang TW et al (2016) Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis 7:e2524","journal-title":"Cell Death Dis"},{"key":"493_CR36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","volume":"111","author":"GM Spaggiari","year":"2008","unstructured":"Spaggiari GM, Capobianco A, Abdelrazik H et al (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327\u20131333","journal-title":"Blood"},{"key":"493_CR37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jbspin.2008.04.004","volume":"75","author":"J Swart","year":"2008","unstructured":"Swart J, Martens A, Wulffraat N (2008) Mesenchymal stem cells: a future for the treatment of arthritis? Joint Bone Spine 75:379\u2013382","journal-title":"Joint Bone Spine"},{"key":"493_CR38","first-page":"3813","volume":"67","author":"J Swart","year":"2015","unstructured":"Swart J, Wulffraat N, Prakken BJ et al (2015) Mesenchymal stromal cell treatment in juvenile idiopathic arthritis: a pilot study [abstract]. Arthritis Rheumatol 67:3813\u20133814","journal-title":"Arthritis Rheumatol"},{"key":"493_CR39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5604\/17322693.1208887","volume":"70","author":"J Swidrowska-Jaros","year":"2016","unstructured":"Swidrowska-Jaros J, Orczyk K, Smolewska E (2016) Macrophages - silent enemies in juvenile idiopathic arthritis. Postepy Hig Med Dosw (Online) 70:743\u2013750","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"493_CR40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nyas.12815","volume":"1351","author":"A Uccelli","year":"2015","unstructured":"Uccelli A, de Rosbo NK (2015) The immunomodulatory function of mesenchymal stem cells: mode of action and pathways. Ann N Y Acad Sci 1351:114\u2013126","journal-title":"Ann N Y Acad Sci"},{"key":"493_CR41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12969-016-0114-4","volume":"14","author":"A Verwoerd","year":"2016","unstructured":"Verwoerd A, Ter Haar NM, de Roock S et al (2016) The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J 14:55","journal-title":"Pediatr Rheumatol Online J"},{"key":"493_CR42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/term.299","volume":"5","author":"S Wakitani","year":"2011","unstructured":"Wakitani S, Okabe T, Horibe S et al (2011) Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 5:146\u2013150","journal-title":"J Tissue Eng Regen Med"},{"key":"493_CR43","doi-asserted-by":"crossref","unstructured":"Wang L, Zhang Y, Li H et al (2016) Clinical observation of employment of umbilical cord derived mesenchymal stem cell for juvenile idiopathic arthritis therapy. Stem Cells Int 2016:9165267","DOI":"10.1155\/2016\/9165267"},{"key":"493_CR44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-016-0285-4","volume":"7","author":"CC Wu","year":"2016","unstructured":"Wu CC, Liu FL, Sytwu HK et al (2016) CD146 + mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther 7:23","journal-title":"Stem Cell Res Ther"},{"key":"493_CR45","doi-asserted-by":"crossref","unstructured":"Zhang Y, Khan D, Delling J et al (2012) Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. Sci World J 2012:793823","DOI":"10.1100\/2012\/793823"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-017-0493-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-017-0493-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-017-0493-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:04Z","timestamp":1704228544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-017-0493-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1007\/s00005-017-0493-3","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"type":"print","value":"0004-069X"},{"type":"electronic","value":"1661-4917"}],"subject":[],"published":{"date-parts":[[2017,10,13]]}}}